Post-treatment surveillance of breast cancer patients in an organized, multidisciplinary setting.
Post-treatment surveillance protocols should include early detection of local, regional, and systemic recurrence, new primary tumors and should address treatment complications and psychosocial needs. In addition to annual mammography, history and physical examination in the treated, asymptomatic breast cancer patient surveillance visits should occur every 3-4 months for 3 years, every 6 months for the next 2 years, and annually thereafter. Scans and other tests should be reserved for high risk or symptomatic patients.